PDB15 A COST-EFFECTIVENESS ANALYSIS OF SWITCHING TYPE-2 DIABETES PATIENTS FROM IMMEDIATE-RELEASE METFORMIN (GLUCOPHAGE) TO A NEW EXTENDEDRELEASE FORMULATION OF METFORMIN (GLUCOPHAGEXR)
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65958-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)65958-X/fulltext
Title :
PDB15 A COST-EFFECTIVENESS ANALYSIS OF SWITCHING TYPE-2 DIABETES PATIENTS FROM IMMEDIATE-RELEASE METFORMIN (GLUCOPHAGE) TO A NEW EXTENDEDRELEASE FORMULATION OF METFORMIN (GLUCOPHAGEXR)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65958-X&doi=10.1016/S1098-3015(10)65958-X
First page :
Section Title :
Open access? :
No
Section Order :
324